Additionally, ISG15 could serve as a potential target for cancer vaccines, such as the ISG15-based Listeria vaccine, which has demonstrated good immunogenicity in CRC immunotherapy [91]. The gene discussed is ISG15; the disease is colorectal carcinoma.